Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector

被引:904
作者
Szymczak, AL
Workman, CJ
Wang, Y
Vignali, KM
Dilioglou, S
Vanin, EF
Vignali, DAA
机构
[1] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Hematol Oncol, Div Expt Hematol, Memphis, TN 38105 USA
[3] Univ Tennessee, Med Ctr, Dept Pathol, Memphis, TN 38163 USA
[4] Univ Tennessee, Med Ctr, Grad Program Pathol, Memphis, TN 38163 USA
关键词
D O I
10.1038/nbt957
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Attempts to generate reliable and versatile vectors for gene therapy and biomedical research that express multiple genes have met with limited success. Here we used Picornavirus 'self-cleaving' 2A peptides, or 2A-like sequences from other viruses(1-3), to generate multicistronic retroviral vectors with efficient translation of four cistrons. Using the T-cell receptor: CD3 complex as a test system, we show that a single 2A peptide-linked retroviral vector can be used to generate all four CD3 proteins (CD3epsilon, gamma, delta, zeta), and restore T-cell development and function in CD3-deficient mice. We also show complete 2A peptide-mediated 'cleavage' and stoichiometric production of two fluorescent proteins using a fluorescence resonance energy transfer-based system in multiple cell types including blood, thymus, spleen, bone marrow and early stem cell progenitors.
引用
收藏
页码:589 / 594
页数:6
相关论文
共 30 条
  • [1] Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins
    Borman, AM
    LeMercier, P
    Girard, M
    Kean, KM
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (05) : 925 - 932
  • [2] T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage
    Carson, RT
    Vignali, KM
    Woodland, DL
    Vignali, DAA
    [J]. IMMUNITY, 1997, 7 (03) : 387 - 399
  • [3] Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO
  • [4] 2-3
  • [5] Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy
    de Felipe, P
    Martín, V
    Cortés, ML
    Ryan, M
    Izquierdo, M
    [J]. GENE THERAPY, 1999, 6 (02) : 198 - 208
  • [6] The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences
    Donnelly, MLL
    Hughes, LE
    Luke, G
    Mendoza, H
    ten Dam, E
    Gani, D
    Ryan, MD
    [J]. JOURNAL OF GENERAL VIROLOGY, 2001, 82 : 1027 - 1041
  • [7] Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'
    Donnelly, MLL
    Luke, G
    Mehrotra, A
    Li, XJ
    Hughes, LE
    Gani, D
    Ryan, MD
    [J]. JOURNAL OF GENERAL VIROLOGY, 2001, 82 : 1013 - 1025
  • [8] GENES WITH PROMOTERS IN RETROVIRUS VECTORS CAN BE INDEPENDENTLY SUPPRESSED BY AN EPIGENETIC MECHANISM
    EMERMAN, M
    TEMIN, HM
    [J]. CELL, 1984, 39 (03) : 459 - 467
  • [9] E(-)-VECTORS - DEVELOPMENT OF NOVEL SELF-INACTIVATING AND SELF-ACTIVATING RETROVIRAL VECTORS FOR SAFER GENE-THERAPY
    JULIAS, JG
    HASH, D
    PATHAK, VK
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (11) : 6839 - 6846
  • [10] Immunotherapy through TCR gene transfer
    Kessels, HWHG
    Wolkers, MC
    van den Boom, MD
    van der Valk, MA
    Schumacher, TNM
    [J]. NATURE IMMUNOLOGY, 2001, 2 (10) : 957 - 961